Article ; Online: In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care reduced all-cause mortality.
2022 Volume 175, Issue 6, Page(s) JC64
Abstract: Source citation: Ely EW, Ramanan AV, Kartman CE, et al. ...
Abstract | Source citation: Ely EW, Ramanan AV, Kartman CE, et al. |
---|---|
MeSH term(s) | Adult ; Azetidines ; COVID-19/drug therapy ; Extracorporeal Membrane Oxygenation ; Humans ; Purines ; Pyrazoles ; SARS-CoV-2 ; Sulfonamides |
Chemical Substances | Azetidines ; Purines ; Pyrazoles ; Sulfonamides ; baricitinib (ISP4442I3Y) |
Language | English |
Publishing date | 2022-06-07 |
Publishing country | United States |
Document type | Journal Article ; Randomized Controlled Trial ; Comment |
ZDB-ID | 336-0 |
ISSN | 1539-3704 ; 0003-4819 |
ISSN (online) | 1539-3704 |
ISSN | 0003-4819 |
DOI | 10.7326/J22-0033 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.178/2: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.